(Note that on November 19, 2024, the parties filed a joint status report in the case where FDA indicated it has not yet made a determination in its reconsideration of the status of tirzepatide and will provide another update to the court on December 19, 2024
Spicy foods may exacerbate nausea in some patients, especially those already experiencing gastrointestinal sensitivity from semaglutide
In various diet-induced animal models of MASLD, downregulation of hepatic NQO1 mRNA levels was reported (Ke et al
LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept Coskun T, Sloop KW, Loghin C, et al
Caballero-Garca, A
We encourage you to contact a WMPG representative for more information